{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:06:16Z","timestamp":1789211176314,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007835","name":"Wenzhou Medical University","doi-asserted-by":"publisher","award":["z2-2023013"],"award-info":[{"award-number":["z2-2023013"]}],"id":[{"id":"10.13039\/100007835","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wenzhou Natural Science Research Foundation","award":["Y20240298"],"award-info":[{"award-number":["Y20240298"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08848-x","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:43:47Z","timestamp":1787237027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SNX8 regulates BMPR2-mediated SMAD5 proteostasis to drive epithelial-mesenchymal transition in hepatocellular carcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Xihao","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuekai","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingzi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangxin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangtao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binglong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"3","key":"8848_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"8848_CR2","first-page":"203","volume":"4","author":"H Zeng","year":"2024","unstructured":"Zeng H, Zheng R, Sun K, Zhou M, Wang S, Li L, et al. Cancer survival statistics in China 2019\u20132021: a multicenter, population-based study. J Natl Cancer Cent. 2024;4(3):203\u201313.","journal-title":"J Natl Cancer Cent"},{"key":"8848_CR3","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2147\/JHC.S342266","volume":"9","author":"D Papaconstantinou","year":"2022","unstructured":"Papaconstantinou D, Tsilimigras DI, Pawlik TM. Recurrent Hepatocellular Carcinoma: Patterns, Detection, Staging and Treatment. J Hepatocell Carcinoma. 2022;9:947\u201357.","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"8848_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"8848_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016;166(1):21\u201345.","journal-title":"Cell"},{"issue":"10","key":"8848_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41571-025-01058-2","volume":"22","author":"EW Thompson","year":"2025","unstructured":"Thompson EW, Redfern AD, Brabletz S, Berx G, Agarwal V, Ganesh K, et al. EMT and cancer: what clinicians should know. Nat Rev Clin Oncol. 2025;22(10):711\u201333.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"8848_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer. 2018;18(2):128\u201334.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"8848_CR8","doi-asserted-by":"publisher","first-page":"e2404083","DOI":"10.1002\/advs.202404083","volume":"12","author":"H Han","year":"2025","unstructured":"Han H, Zhang C, Shi W, Wang J, Zhao W, Du Y, et al. NSUN5 Facilitates Hepatocellular Carcinoma Progression by Increasing SMAD3 Expression. Adv Sci (Weinh). 2025;12(2):e2404083.","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"8848_CR9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41556-021-00694-x","volume":"23","author":"K Scheibner","year":"2021","unstructured":"Scheibner K, Schirge S, Burtscher I, B\u00fcttner M, Sterr M, Yang D, et al. Epithelial cell plasticity drives endoderm formation during gastrulation. Nat Cell Biol. 2021;23(7):692\u2013703.","journal-title":"Nat Cell Biol"},{"key":"8848_CR10","doi-asserted-by":"publisher","first-page":"217161","DOI":"10.1016\/j.canlet.2024.217161","volume":"600","author":"M Lu","year":"2024","unstructured":"Lu M, Gong X, Zhang YM, Guo YW, Zhu Y, Zeng XB, et al. Platelets promote primary hepatocellular carcinoma metastasis through TGF-\u03b21-mediated cancer cell autophagy. Cancer Lett. 2024;600:217161.","journal-title":"Cancer Lett"},{"issue":"3","key":"8848_CR11","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3350\/cmh.2024.1038","volume":"31","author":"HS Kim","year":"2025","unstructured":"Kim HS, Yoon JH, Choi JY, Yoon MG, Baek GO, Kang M, et al. GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma. Clin Mol Hepatol. 2025;31(3):914\u201334.","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"8848_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40364-025-00785-z","volume":"13","author":"R Yang","year":"2025","unstructured":"Yang R, Wang H, Wu C, Shi Y, Li H, Bao X, et al. PAQR5 drives the malignant progression and shapes the immunosuppressive microenvironment of hepatocellular carcinoma by activating the NF-\u03baB signaling. Biomark Res. 2025;13(1):70.","journal-title":"Biomark Res"},{"key":"8848_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2017.01.037","volume":"392","author":"A Malfettone","year":"2017","unstructured":"Malfettone A, Soukupova J, Bertran E, Crosas-Molist E, Lastra R, Fernando J, et al. Transforming growth factor-\u03b2-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma. Cancer Lett. 2017;392:39\u201350.","journal-title":"Cancer Lett"},{"key":"8848_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12943-016-0511-9","volume":"15","author":"DJ Augeri","year":"2016","unstructured":"Augeri DJ, Langenfeld E, Castle M, Gilleran JA, Langenfeld J. Inhibition of BMP and of TGF\u03b2 receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death. Mol Cancer. 2016;15:27.","journal-title":"Mol Cancer"},{"issue":"2","key":"8848_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jhep.2025.08.022","volume":"84","author":"H Zhou","year":"2026","unstructured":"Zhou H, Ba J, Xiao C, Liu H, Jiang J, Guo Y, et al. Alcohol activates ATF4\/LPLA2-mediated BMP metabolism to enhance HBV-induced hepatocellular carcinogenesis. J Hepatol. 2026;84(2):339\u201354.","journal-title":"J Hepatol"},{"key":"8848_CR16","doi-asserted-by":"crossref","unstructured":"Li X, Wu Y, Tian T. TGF-\u03b2 Signaling in Metastatic Colorectal Cancer (mCRC): From Underlying Mechanism to Potential Applications in Clinical Development. Int J Mol Sci. 2022;23(22).","DOI":"10.3390\/ijms232214436"},{"issue":"1","key":"8848_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ncb2374","volume":"14","author":"PJ Cullen","year":"2011","unstructured":"Cullen PJ, Korswagen HC. Sorting nexins provide diversity for retromer-dependent trafficking events. Nat Cell Biol. 2011;14(1):29\u201337.","journal-title":"Nat Cell Biol"},{"issue":"5\u20136","key":"8848_CR18","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s10495-025-02088-y","volume":"30","author":"LH Qian","year":"2025","unstructured":"Qian LH, Wen KL, Guo Y, Liao YN, Li MY, Li ZQ, et al. Nutrient deficiency-induced downregulation of SNX1 inhibits ferroptosis through PPARs-ACSL1\/4 axis in colorectal cancer. Apoptosis. 2025;30(5\u20136):1391\u2013409.","journal-title":"Apoptosis"},{"key":"8848_CR19","doi-asserted-by":"crossref","unstructured":"Yang L, Tan W, Yang X, You Y, Wang J, Wen G et al. Sorting nexins: A novel promising therapy target for cancerous\/neoplastic diseases. J Cell Physiol. 2020.","DOI":"10.1002\/jcp.30093"},{"issue":"17","key":"8848_CR20","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/s41388-025-03298-z","volume":"44","author":"Y Le","year":"2025","unstructured":"Le Y, Zhou L, He Y, Zhou J, Zhan J, Zhang H, et al. SNX5 facilitates the progression of gastric cancer by increasing the membrane localization of LRP5. Oncogene. 2025;44(17):1182\u201396.","journal-title":"Oncogene"},{"issue":"10","key":"8848_CR21","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1038\/s41388-019-1131-9","volume":"39","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Huang T, Jiang Z, Ge C, Chen X, Zhang L, et al. Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1\/2 signaling pathway. Oncogene. 2020;39(10):2140\u201355.","journal-title":"Oncogene"},{"issue":"9","key":"8848_CR22","doi-asserted-by":"publisher","first-page":"13287","DOI":"10.18632\/aging.203013","volume":"13","author":"Y Han","year":"2021","unstructured":"Han Y, Liu Y, Zhang B, Yin G. Exosomal circRNA 0001445 promotes glioma progression through miRNA-127-5p\/SNX5 pathway. Aging. 2021;13(9):13287\u201399.","journal-title":"Aging"},{"issue":"6","key":"8848_CR23","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.7150\/ijbs.110506","volume":"21","author":"Y Liu","year":"2025","unstructured":"Liu Y, Tian W, Ge C, Zhang C, Huang Z, Zhang C, et al. SNX17 mediates STAT3 activation to promote hepatocellular carcinoma progression via a retromer dependent mechanism. Int J Biol Sci. 2025;21(6):2762\u201379.","journal-title":"Int J Biol Sci"},{"key":"8848_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.canlet.2018.01.045","volume":"419","author":"S Zhang","year":"2018","unstructured":"Zhang S, Hu B, You Y, Yang Z, Liu L, Tang H, et al. Sorting nexin 10 acts as a tumor suppressor in tumorigenesis and progression of colorectal cancer through regulating chaperone mediated autophagy degradation of p21(Cip1\/WAF1). Cancer Lett. 2018;419:116\u201327.","journal-title":"Cancer Lett"},{"issue":"1","key":"8848_CR25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41698-025-00973-y","volume":"9","author":"D Egan","year":"2025","unstructured":"Egan D, Glennon K, Treacy A, Fabre A, McCormack J, Hill S, et al. A temporal model of tumor-immune dynamics during the metastatic progression of high-grade serous ovarian cancer. NPJ Precis Oncol. 2025;9(1):188.","journal-title":"NPJ Precis Oncol"},{"issue":"3","key":"8848_CR26","first-page":"227","volume":"12","author":"N Zhang","year":"2024","unstructured":"Zhang N, Yang P, Li Y, Ouyang Q, Hou F, Zhu G, et al. Serum Iron Overload Activates the SMAD Pathway and Hepcidin Expression of Hepatocytes via SMURF1. J Clin Transl Hepatol. 2024;12(3):227\u201335.","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"8848_CR27","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","volume":"79","author":"AD Ladd","year":"2024","unstructured":"Ladd AD, Duarte S, Sahin I, Zarrinpar A. Mechanisms of drug resistance in HCC. Hepatology. 2024;79(4):926\u201340.","journal-title":"Hepatology"},{"key":"8848_CR28","doi-asserted-by":"publisher","first-page":"102135","DOI":"10.1016\/j.mtbio.2025.102135","volume":"34","author":"B Bai","year":"2025","unstructured":"Bai B, Zheng Z, Zhu B, Wu J, Xu Y, Zhong X, et al. An Fe(III)-covalent organic framework (COF)-sorafenib nanoplatform induces chemo-ferroptosis for enhanced hepatocellular carcinoma immunotherapy. Mater Today Bio. 2025;34:102135.","journal-title":"Mater Today Bio"},{"issue":"3","key":"8848_CR29","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41556-026-01879-y","volume":"28","author":"A B\u00e5ng-Rudenstam","year":"2026","unstructured":"B\u00e5ng-Rudenstam A, Cerezo-Maga\u00f1a M, Horvath M, Talbot H, Gustafsson E, Jonathan S, et al. Tumour acidosis remodels the glycocalyx to control lipid scavenging and ferroptosis. Nat Cell Biol. 2026;28(3):567\u201380.","journal-title":"Nat Cell Biol"},{"key":"8848_CR30","doi-asserted-by":"crossref","unstructured":"Ghafoor S, Garcia E, Jay DJ, Persad S. Molecular Mechanisms Regulating Epithelial Mesenchymal Transition (EMT) to Promote Cancer Progression. Int J Mol Sci. 2025;26(9).","DOI":"10.3390\/ijms26094364"},{"issue":"1","key":"8848_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13619-023-00181-8","volume":"12","author":"W Zhou","year":"2023","unstructured":"Zhou W, Yan K, Xi Q. BMP signaling in cancer stemness and differentiation. Cell Regen. 2023;12(1):37.","journal-title":"Cell Regen"},{"issue":"2","key":"8848_CR32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.stem.2020.06.017","volume":"27","author":"M Zabala","year":"2020","unstructured":"Zabala M, Lobo NA, Antony J, Heitink LS, Gulati GS, Lam J, et al. LEFTY1 Is a Dual-SMAD Inhibitor that Promotes Mammary Progenitor Growth and Tumorigenesis. Cell Stem Cell. 2020;27(2):284\u2013. \u2013\u200999.e8.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"8848_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13045-019-0795-5","volume":"12","author":"Y Dong","year":"2019","unstructured":"Dong Y, Zheng Q, Wang Z, Lin X, You Y, Wu S, et al. Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis. J Hematol Oncol. 2019;12(1):112.","journal-title":"J Hematol Oncol"},{"issue":"Pt A","key":"8848_CR34","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ijbiomac.2022.09.203","volume":"222","author":"M Hashemi","year":"2022","unstructured":"Hashemi M, Hasani S, Hajimazdarany S, Mirmazloomi SR, Makvandy S, Zabihi A, et al. Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance. Int J Biol Macromol. 2022;222(Pt A):1151\u201367.","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"8848_CR35","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/j.ymthe.2021.02.016","volume":"29","author":"J Ning","year":"2021","unstructured":"Ning J, Ye Y, Bu D, Zhao G, Song T, Liu P, et al. Imbalance of TGF-\u03b21\/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness. Mol Ther. 2021;29(6):2067\u201387.","journal-title":"Mol Ther"},{"key":"8848_CR36","doi-asserted-by":"publisher","first-page":"1619359","DOI":"10.3389\/fcell.2025.1619359","volume":"13","author":"L Wang","year":"2025","unstructured":"Wang L, Guo J, Lv C, Kong L, Cui J, Wang Z, et al. MiR-145-5p arrests the cell cycle by modulating SMAD5\/cyclin D1 to inhibit gastric cancer progression. Front Cell Dev Biol. 2025;13:1619359.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"8848_CR37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41419-025-07567-3","volume":"16","author":"D Du","year":"2025","unstructured":"Du D, Zhang W, Zhang D, Liu L, Li J, Chen Z, et al. NUB1 reduction promotes PCNA-mediated tumor growth by disturbing the PCNA polyubiquitination\/NEDDylation in hepatocellular carcinoma cells. Cell Death Dis. 2025;16(1):228.","journal-title":"Cell Death Dis"},{"issue":"1","key":"8848_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s43586-022-00118-6","volume":"2","author":"CM Leung","year":"2022","unstructured":"Leung CM, de Haan P, Ronaldson-Bouchard K, Kim G-A, Ko J, Rho HS, et al. A guide to the organ-on-a-chip. Nat Reviews Methods Primers. 2022;2(1):33.","journal-title":"Nat Reviews Methods Primers"},{"key":"8848_CR39","doi-asserted-by":"crossref","unstructured":"Surina S, Chmielewska A, Pratscher B, Freund P, Rodr\u00edguez-Rojas A, Burgener IA. Organ-on-a-Chip: A Roadmap for Translational Research in Human and Veterinary Medicine. Int J Mol Sci. 2025;26(21).","DOI":"10.3390\/ijms262110753"},{"issue":"2","key":"8848_CR40","doi-asserted-by":"publisher","first-page":"9420013","DOI":"10.26599\/FMH.2024.9420013","volume":"1","author":"X Wang","year":"2024","unstructured":"Wang X, Miao Y-H, Zhao X-M, Liu X, Hu Y-W, Deng D-W. Perspectives on organ-on-a-chip technology for natural products evaluation. Food Med Homology. 2024;1(2):9420013.","journal-title":"Food Med Homology"},{"issue":"4","key":"8848_CR41","doi-asserted-by":"publisher","first-page":"e20240134","DOI":"10.1002\/INMD.20240134","volume":"3","author":"Y Shi","year":"2025","unstructured":"Shi Y, Fan R. Racing toward the future of chronic hepatitis B management: Achieving functional cure and enhancing hepatocellular carcinoma surveillance through precision medicine. Interdisciplinary Med. 2025;3(4):e20240134.","journal-title":"Interdisciplinary Med"},{"issue":"11","key":"8848_CR42","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","volume":"42","author":"C Galassi","year":"2024","unstructured":"Galassi C, Chan TA, Vitale I, Galluzzi L. The hallmarks of cancer immune evasion. Cancer Cell. 2024;42(11):1825\u201363.","journal-title":"Cancer Cell"},{"issue":"8025","key":"8848_CR43","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41586-024-07722-4","volume":"632","author":"A Bodansky","year":"2024","unstructured":"Bodansky A, Mettelman RC, Sabatino JJ Jr., Vazquez SE, Chou J, Novak T, et al. Molecular mimicry in multisystem inflammatory syndrome in children. Nature. 2024;632(8025):622\u20139.","journal-title":"Nature"},{"issue":"4","key":"8848_CR44","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, He Y, Luo N, Patel SJ, Han Y, Gao R, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179(4):829\u2013e4520.","journal-title":"Cell"},{"key":"8848_CR45","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.2147\/OTT.S336548","volume":"14","author":"X Ma","year":"2021","unstructured":"Ma X, Gao Y, Chen Y, Liu J, Yang C, Bao C, et al. M2-Type Macrophages Induce Tregs Generation by Activating the TGF-\u03b2\/Smad Signalling Pathway to Promote Colorectal Cancer Development. Onco Targets Ther. 2021;14:5391\u2013402.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"8848_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","volume":"8","author":"S Wang","year":"2024","unstructured":"Wang S, Wang J, Chen Z, Luo J, Guo W, Sun L, et al. Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. NPJ Precis Oncol. 2024;8(1):31.","journal-title":"NPJ Precis Oncol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08848-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08848-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08848-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:22:26Z","timestamp":1789208546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08848-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8848"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08848-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Studies involving human participants were viewed and approved by the Medical Institutional Review Boards in Shanghai (Approval No. YB M-05-01) and the Ethics Committee of the Second Affiliated Hospital of Wenzhou Medical University (Approval No. 2025-K-340-01). The procedures employed in this study adhered to the principles of the Declaration of Helsinki. The animal experiment procedure was performed in accordance with the Guideline for the Care and Use of Laboratory Animals (GB\/T 35892\u2009\u2212\u20092018) and was approved by the Institutional Animal Care and Use Committee of Wenzhou Institute, University of Chinese Academy of Sciences (Approval No. WIUCAS25020601).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors read and approved the final manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1180"}}